Kanabo Group plc (LSE: KNB), a digital health company that specialises in patient-focused services and medicinal cannabis, announced on Tuesday that it has extended its contract with a prominent UK health and beauty retail and e-pharmacy services provider.
Originally partnering in 2019, the extension, facilitated through Kanabo's telehealth platform, The GP Service, grants the retailer continued access to video consultations and prescription services for another 12 months. The extension expands Kanabo's patient base, providing faster and more accessible healthcare through over 4,000 UK pharmacies.
The company is dedicated to transforming patient care through its digital health platform, offering regulated medicinal cannabis-derived formulations and inhalation devices. Its NHS-approved telehealth platform, The GP Service, provides video consultations, online prescriptions and primary care services, with additional offerings like Treat It, an online clinic focusing on chronic pain management. Kanabo's comprehensive approach includes a subsidiary, Kanabo Agritec Ltd, supporting cannabis businesses in cultivation for high-quality raw materials.
Genedrive receives FDA Breakthrough Device Designation for infant hearing loss test
Mainz Biomed seeks FDA fast track for next-gen colorectal cancer test
Neuromod Devices names new general counsel
Delta-Fly Pharma initiates Phase III trial for lung cancer drug DFP-14323
Igraine plc investee Fixit Medical secures GBP270,000 Innovate UK grant
Pulnovo Medical enrols first two patients in PADN technology global multicentre clinical study
Getinge introduces CE-certified Pulsiocare for advanced hemodynamic monitoring
CND Life Sciences announces new appointments to leadership team
Tempus announces receipt of FDA clearance for AI-based AFib risk detection
bioMérieux receives FDA clearance for VITEK REVEAL AST System
CLS secures order from ClearPoint Neuro for North American launch
Bausch + Lomb to present new data at European Dry Eye Society 2024 Congress